Home >> MAPK >>

p38 MAPK

p38 mapks (P38 mitogen-activated protein kinases) which include p38 isoforms α, β, γ, and δ are a member of mitogen-activated protein kinases family. p38 mapk can be activated by LPS, proinflammatory cytokines, various environmental stresses. p38 MAPK phosphorylates various substrates including MAPK-activated protein kinase 2 (MAPKAPK2). p38 MAPK which is activated in the human brain with Alzheimer’s disease plays more than one role in Alzheimer's disease (AD).

Inhibitors

Cat.No. Product Name Information Publication Customer Review
S1076 SB 203580 SB203580 is a p38 MAPK inhibitor with IC50 of 0.3-0.5 μM and blocks PKB phosphorylation with IC50 of 3-5 μM. (8)
S1574 BIRB 796 (Doramapimod) BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM. (5)
S1077 SB 202190 SB 202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38α and p38β with IC50 of 50 nM and 100 nM, respectively. (1)
S1494 LY2228820 LY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM. (3)
S6005 VX-702 VX-702 is a highly selective inhibitor of p38 MAPKα with IC50 of 4-20 nM.
S2726 PH-797804 PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM.
S1458 VX-745 VX-745 is a potent and selective inhibitor of p38α MAPK and p38β MAPK with IC50 of 10 nM and 220 nM, respectively. (1)
S2928 TAK 715 TAK 715 is a p38 MAPK inhibitor for p38α with IC50 of 7.1 nM.

p38 MAPK

Related Targets

Download Catalogs & Flyers

Download Inhibitor Catalog

Your Recent History